Product — Revenue
Regeneron Pharmaceuticals Product — Revenue decreased by 8.4% to $1.53B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.4%, from $1.42B to $1.53B. Over 4 years (FY 2021 to FY 2025), Product — Revenue shows a downward trend with a -15.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing market demand and successful commercial execution, while a decrease may signal competitive pressure, patent expirations, or market saturation.
Detailed definition
This metric represents the total revenue generated from the sale of pharmaceutical products after accounting for returns...
Peer comparison
Comparable to net product revenue reported by other large-cap biopharmaceutical companies, often adjusted for collaboration revenue sharing agreements.
regn_segment_net_product_sales_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.14B | $2.28B | $3.98B | $1.64B | $1.75B | $1.80B | $1.70B | $1.67B | $1.77B | $1.79B | $1.85B | $1.76B | $1.92B | $1.95B | $2.00B | $1.42B | $1.63B | $1.59B | $1.67B | $1.53B |
| QoQ Change | — | -44.9% | +74.4% | -58.8% | +7.1% | +2.7% | -5.7% | -1.8% | +6.2% | +0.8% | +3.7% | -4.9% | +8.9% | +1.4% | +2.9% | -29.3% | +15.2% | -2.7% | +5.5% | -8.4% |
| YoY Change | — | — | — | — | -57.6% | -21.0% | -57.3% | +1.8% | +1.0% | -0.8% | +9.0% | +5.6% | +8.3% | +9.0% | +8.2% | -19.6% | -15.0% | -18.4% | -16.4% | +8.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's product — revenue?
- Regeneron Pharmaceuticals (REGN) reported product — revenue of $1.53B in Q1 2026.
- How has Regeneron Pharmaceuticals's product — revenue changed year-over-year?
- Regeneron Pharmaceuticals's product — revenue increased by 8.4% year-over-year, from $1.42B to $1.53B.
- What is the long-term trend for Regeneron Pharmaceuticals's product — revenue?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's product — revenue has grown at a -15.1% compound annual growth rate (CAGR), from $12.12B to $6.31B.
- What does product — revenue mean?
- The total amount of money earned from selling pharmaceutical products after accounting for discounts and returns.